comparemela.com

Latest Breaking News On - Junior associate professor kazuo takayama - Page 1 : comparemela.com

Micro-patterning: A new system to induce alveolar and airway epithelial cells

Micro-patterning: A new system to induce alveolar and airway epithelial cells
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

A microscopic multi-organ model to study bronchi-vasculature interactions during SARS-CoV-2 infections

A microscopic multi-organ model to study bronchi-vasculature interactions during SARS-CoV-2 infections
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Analysis of the 2022 mpox virus using human keratinocytes and human iPS cell-derived colon organoids

Analysis of the 2022 mpox virus using human keratinocytes and human iPS cell-derived colon organoids
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Stem cells show gender differences in COVID-19 risk

Kyoto University Graphical abstract The Kazuo Takayama lab shows how iPS cells can be used to study SARS-CoV-2 and COVID-19. With more than 125 million people infected and nearly 3 million dead, the COVID-19 pandemic has disrupted the world in inconceivable ways. Adding to the challenge is that the patient condition varies widely, from the asymptomatic to respiratory failure and death. A new study by CiRA researchers shows how iPS cells can be used to study infection by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), revealing gender differences seen with the disease. One of the devasting aspects of COVID-19 is its unpredictable nature. An unknown number of people infected are asymptomatic, and those that do show symptoms range widely, from mild to severe.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.